AlphaYouIMVT: Van Tuyl Christopher discloses a sale
By AlphaYouPublished Form 4
Van Tuyl Christopher
Reporting filer
Van Tuyl Christopher reported Sale in Immunovant, Inc.: 2846 units of Common Stock, dated 2026-09-23. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 25, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Van Tuyl Christopher | 2026-09-23 | S | Sale | 2846 | 36.36 | 176,545 | 2 days | Filed terms
|
Common Stock
- Owner
- Van Tuyl Christopher
- Date
- 2026-09-23
- Code
- S
- Action
- Sale
- Quantity
- 2846
- Price
- 36.36
- Following holdings
- 176,545
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-23
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 2846
- id: F1
- transaction Price Per Share: 36.36
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 176545
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Van Tuyl Christopher: Chief Legal Officer.
- F1: On December 16, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on December 18, 2024, of which 6,872 of these RSUs vested on September 16, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.35 - $36.66 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Original sources
Prepared automatically from public filing data. Report a correction.